APAC IPOs & Placements, Aequitas Research

Akshat Shah

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Anthem Biosciences / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/anthem-biosciences" target="_blank" data-smartkarma-citation="entities:44206:1" rel="noopener">Anthem Biosciences (1234D IN)</a> is looking to raise up to US$400m in its upcoming India IPO.</li>
<li>Anthem Biosciences (ABS) is a contract research, development and manufacturing organisation (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing.</li>
<li>In this note, we talk about the not-so-positive aspects of the deal.</li>
</ul>



Anthem Biosciences (1234D IN) is looking to raise up to US$400m in its upcoming India IPO.
Anthem Biosciences (ABS) is a contract research, development and manufacturing organisation (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing.
In this note, we talk about the not-so-positive aspects of the deal.


Anthem Biosciences Pre-IPO - The Negatives- Margins Aren't There Yet

Market & Forensics Analyst, Beat the Street

Nimish Maheshwari

Market & Forensics Analyst

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Thematic (Sector/Industry)

<ul>
<li>The packaging sector is making a comeback as key material spreads have been rising  which is being reflected in Q1FY25 results of the companies.</li>
<li>What makes this sector more interesting is certain promoters of these companies are buying share of the company from the open market along with fund infusion by some big investors</li>
<li>The biggest risk remains for the sector is pricing pressure and demand-supply mismatch but it seems bottom is being made for the sector</li>
</ul>


The packaging sector is making a comeback as key material spreads have been rising  which is being reflected in Q1FY25 results of the companies.
What makes this sector more interesting is certain promoters of these companies are buying share of the company from the open market along with fund infusion by some big investors
The biggest risk remains for the sector is pricing pressure and demand-supply mismatch but it seems bottom is being made for the sector


Thematic Report : Packaging Sector Is Back with Bang: What’s Fueling Revival?

India

Uflex Ltd. manufactures flexible and laminated packaging.  The Company's products are used in packaging for cosmetics, pharmaceuticals and toiletries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Uflex Ltd (UFLX IN)

Anthem Biosciences Pre-IPO - The Negatives- Margins Aren't There Yet

Anthem Biosciences is looking to raise up to US$400m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.

Akshat Shah

Thematic Report : Packaging Sector Is Back with Bang: What’s Fueling Revival?

Packaging sector sees resurgence in Q1FY25 with rising material costs, promoter and investor interest, despite pricing pressure and demand-supply...

Nimish Maheshwari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Anthem Biosciences Pre-IPO - The Negatives- Margins Aren't There Yet

Anthem Biosciences is looking to raise up to US$400m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.

Akshat Shah

Thematic Report : Packaging Sector Is Back with Bang: What’s Fueling Revival?

​Packaging sector sees resurgence in Q1FY25 with rising material costs, promoter and investor interest, despite pricing pressure and demand-supply...

Nimish Maheshwari

Packaging sector sees resurgence in Q1FY25 with rising material costs, promoter and investor interest, despite pricing pressure and demand-supply...